Data suggest that, in the United States, there is a growing reliance on industry to conduct clinical cancer research.

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

With the perpetual rise of technology and the proliferation of AI, we are moving faster than ever. New inventions have accelerated nearly every aspect of our lives, including medicine. In 2023, the ...

LVS Advisory discusses an investment they made in Medpace in the third quarter of 2024. Click here to read more about their ...

Regular Abstracts Accepted as Poster Presentations Presentation Title: Soluble Immune Biomarker Profiling of Chronic Hepatitis B Subjects Treated with Imdusiran in Combination with Pegylated ...

For the first nine months of 2024, The LVS Growth Portfolio gained 27.1% and the LVS Event-Driven Portfolio gained 4.9%, net ...

Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools. According to ...

UCSF Health is opening retail pharmacies at its Mission Bay and Parnassus campuses. The new pharmacies build on UCSF Health’s ...

Through project PROTECT, a new method for dosing could support individuals suffering from cystic fibrosis ...

AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...

More than 8 million people, ages 40 and older, living in the U.S. are affected by peripheral arterial disease, a lifelong medical condition and the most common cause of limb amputation in the country.